Summary
This prediction ended on 27.01.22 with a price of €27.74. The BUY prediction by krebskrebs for Inpixon performed very badly with a performance of -71.11%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Inpixon | - | - | - | - |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % | 49,60 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % | 80,87 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % | 60,37 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % | 60,00 % |
Comments by krebskrebs for this prediction
In the thread Inpixon diskutieren
In the thread Trading Inpixon
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten